Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV

Rodriguez, Violeta J.; Alcaide, María L.; Salazar, Ana S.; Montgomerie, Emily; Maddalon, Marissa; Jones, Deborah L.

doi:10.1007/s10461-021-03350-5

Cited by 26 publications

(34 citation statements)

References 23 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the process of development of the COVID-19 Vaccine Hesitancy Scale (CoVaH) we considered former highlights from the literature connected specifically to COVID-19 vaccine hesitancy and other vaccine hesitancy studies. Some of these highlighted the role of skepticism and vaccine risk in vaccine hesitancy, 10 , 18–20 others dealt with media and online misinformation, 22 fear of needles, 15 vaccine risks and lack of confidence in benefits of vaccination, 20 conspiracy theories, mistrust, 10 and also uncertainty in newer vaccines. 11 , 12 …”

Section: Discussionmentioning

confidence: 99%

“… 10 , 18 Vaccine hesitancy was correlated with factors like vaccine risks and lack of confidence in the beneficial effects of vaccines in three distinct cultural environments. 19 , 20 Misinformation and conspiracy beliefs predict vaccine hesitancy through putting more emphasis on side effects and undesirable social control. 10 , 21 The negative influence of media contribute to low rates of immunization even in well-developed countries.…”

Section: Introductionmentioning

confidence: 99%

“… 26 , 27 Fear associated negative biases (e. g. negative framing, focus on negative information) were evinced in the literature in health related 19 , 23 , 25 and COVID-19 related information processing. 10 , 20 The fear relates to negative cognitive bias, which can make the vaccine risk seem greater, and skepticism toward the benefits of the vaccines appears. 26 , 28 …”

Section: Introductionmentioning

confidence: 99%

“…The second scale is the Vaccine Hesitancy Scale for COVID-19 Vaccination . 20 This covers two factors: “Lack of confidence” and “Risks” and was adapted for HIV patients. The 10-item scale assesses vaccine risk perception and vaccine confidence and was adapted for COVID-19 from the original Vaccine Hesitancy Scale.…”

Section: Introductionmentioning

confidence: 99%

“…The possible threats of the COVID-19 pandemic can justify the addition of the fear factor, which was not considered in former COVID-19 vaccine hesitancy scales. 10 , 20 …”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale

Kotta

Kálcza-Jánosi

Szabó

et al. 2021

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

The aim of the study was to develop and validate the Multidimensional Covid-19 Vaccine Hesitancy Scale (CoVaH), a self-report measure to assess the beliefs and attitudes beneath vaccination hesitancy and reasons for vaccine refusal in the context of Covid-19. A sample of 1503 Hungarian respondents filled out the scale. Exploratory and confirmatory factor analysis was conducted to identify latent constructs underlying participants′ responses. Findings show a robust three-factor solution for the 15-item CoVaH with high factor loadings on each factor: skepticism, risk perception and fear of Covid-19 vaccine. The CoVaH displayed very good fit indices (KMO = .94, RMSEA = 0.049, CFI = .983) and internal consistencies (α values > .89) and was found to have proper convergent, concurrent and discriminant validity in identifying Covid-19 vaccine hesitancy in the general population. The new scale adds to the literature through the identification of the fear of COVID-19 vaccines, as a newly highlighted explanatory variable of COVID-19 vaccine hesitancy, besides the other formerly identified components. The scale, available in English and Hungarian, allows the assessment of vaccine uptake hesitancy and has the potential to help targeted interventions, considering individual factors that interfere with vaccination acceptance.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

“…The possible threats of the COVID-19 pandemic can justify the addition of the fear factor, which was not considered in former COVID-19 vaccine hesitancy scales. 10 , 20 …”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale

Kotta

Kálcza-Jánosi

Szabó

et al. 2021

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian Survey

et al. 2023

View full text Add to dashboard Cite

Understanding the roots of Covid-19 vaccine hesitancy in at-risk groups, such as persons living with HIV (PLWH), is of utmost importance. We developed a modified Vaccine Hesitancy Scale (VHS) questionnaire using items from the National Advisory Committee on Immunization Acceptability Matrix. To examine factors associated with receiving COVID-19 vaccine and the link between vaccine attitudes and beliefs with vaccine behavior, PLWH were recruited via social media and community-based organizations (February-May 2022). Descriptive statistics were used to summarize results. Total VHS score was generated by adding Likert scale scores and linear regression models used to compare results between participants who received or did not receive COVID-19 vaccines. Logistic regression models were used to identify factors associated with vaccine uptake. A total of 246 PLWH indicated whether they received a COVID-19 vaccine. 89% received ≥ 1 dose. Mean total VHS(SD) for persons having received ≥ 1 COVID-19 vaccine was 17.8(6.2) vs. 35.4(9.4) for participants not having received any COVID-19 vaccine. Persons who received ≥ 1 dose were significantly older than those who had not received any (48.4 ± 13.8 vs. 34.0 ± 7.7 years, p < 0.0001). The majority of participants considered COVID-19 vaccination important for their health(81.3%) and the health of others(84.4%). Multivariate logistic regression revealed the odds of taking ≥ 1dose were increased 2.4-fold [95% CI 1.6, 3.5] with each increase in age of 10 years (p < 0.0001). Sex and ethnicity were not different between groups. In conclusion, PLWH accept COVID-19 vaccines for both altruistic and individual reasons. With evolving recommendations and increasing numbers of booster vaccines, we must re-examine the needs of PLWH regularly.

show abstract

Covid-19 Vaccine Hesitancy and Under-Vaccination among Marginalized Populations in the United States and Canada: A Scoping Review

Newman,

Dinh,

Nyoni

et al. 2023

J. Racial and Ethnic Health Disparities

View full text Add to dashboard Cite

Background Amid persistent disparities in Covid-19 vaccination and burgeoning research on vaccine hesitancy (VH), we conducted a scoping review to identify multilevel determinants of Covid-19 VH and under-vaccination among marginalized populations in the U.S. and Canada. Methods Using the scoping review methodology developed by the Joanna Briggs Institute, we designed a search string and explored 7 databases to identify peer-reviewed articles published from January 1, 2020–October 25, 2022. We combine frequency analysis and narrative synthesis to describe factors influencing Covid-19 VH and under-vaccination among marginalized populations. Results The search captured 11,374 non-duplicated records, scoped to 103 peer-reviewed articles. Among 14 marginalized populations identified, African American/Black, Latinx, LGBTQ+, American Indian/Indigenous, people with disabilities, and justice-involved people were the predominant focus. Thirty-two factors emerged as influencing Covid-19 VH, with structural racism/stigma and institutional mistrust (structural)(n = 71) most prevalent, followed by vaccine safety (vaccine-specific)(n = 62), side effects (vaccine-specific)(n = 50), trust in individual healthcare provider (social/community)(n = 38), and perceived risk of infection (individual)(n = 33). Structural factors predominated across populations, including structural racism/stigma and institutional mistrust, barriers to Covid-19 vaccine access due to limited supply/availability, distance/lack of transportation, no/low paid sick days, low internet/digital technology access, and lack of culturally- and linguistically-appropriate information. Discussion We identified multilevel and complex drivers of Covid-19 under-vaccination among marginalized populations. Distinguishing vaccine-specific, individual, and social/community factors that may fuel decisional ambivalence, more appropriately defined as VH, from structural racism/structural stigma and systemic/institutional barriers to vaccination access may better support evidence-informed interventions to promote equity in access to vaccines and informed decision-making among marginalized populations.

show abstract

Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV

Cited by 26 publications

References 23 publications

Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale

Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale

Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian Survey

Covid-19 Vaccine Hesitancy and Under-Vaccination among Marginalized Populations in the United States and Canada: A Scoping Review

Contact Info

Product

Resources

About